Kvernebo, K. “Erythromelalgia: A Condition Caused by Microvascular Arteriovenous Shunting.” VASA, Nov. 1998; Supplement 51:1-40. |
Drug Facts and Comparisons, Facts and Comparisons, Chapter 1, Nutritional Products, a Wolters Kluwer Company, St. Louis, 1993-1997. |
Mangat, H.S., “Nebulized Magnesium Sulphate Versus Nebulized Salbutamol in Acute Bronchial Asthma: A Clinical Trial”, European Respiratory Journal, Aug. 1998, 12(2):341-4. |
Sueta, C.A. et al, “Antiarrhythmic Action of Pharmacological Administration of Magnesium in Heart Failure: A Critical Review of New Data”, Magnesium Research, Dec. 1995, 8(4):389-401. |
Saris NE; Mervaala E; Karppanen H; Khawaja JA; Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clinica Chimica Acta, Apr. 2000, 294(1-2):1-26. |
Mauskop, A. et al., “Intravenous Magnesium Sulfate Rapidly Alleviates Headaches of Various Types”, Headache, Mar. 1996, 36(3):154-60. |
Mauskop, A., “Role of Magnesium in the Pathogenesis and Treatment of Migraines”, Clinical Neuroscience, 1998, 5(1):24-7. |
Itoh, K. et al., “The Effects of High Oral Magnesium Supplementation on Blood Pressure, Serum Lipids and Related Variables in Apparently Healthy Japanese Subjects” British Journal of Nutrition, Nov. 1997, 78(5):737-50. |
Ryan, M.P., et al., “The Role of Magnesium in the Prevention and Control of Hypertension”, Annals of Clinical Research, 1984, 16 Suppl 43:81-8. |
Widman, L., et al., “The Dose-Dependent Reduction in Blood Pressure Through Administration of Magnesium, A Double Blind Placebo Controlled Cross-Over Study”, American Journal of Hypertension, Jan. 1993, 6(1):41-5. |
Gianni, A.J. et al., “Magnesium Oxide Augmentation of Verapamil Maintenance Therapy in mania”, Psychiatry Research, Feb. 14, 2000, 93(1):83-7. |
Galland, L.D., et al., “Magnesium Deficiency in the Pathogenesis of Mitral Valve Prolapse”, Magnesium, 1986, 5(3-4):165-74. |
Bilbey, D.L., “Muscle Cramps and Magnesium Deficiency: Case Reports”, Canadian Family Physician, Jul. 1996, 42:1348-51. |
Crosby, V., et al., “The Safety and Efficacy of a Single Dose (500 mg or 1g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Stong Opioid Anagesics in Patients with Cancer”, Journal of Pain and Symptom Management, Jan. 2000, 19(1):35-9. |
Tanaka, M., et al. “Relief of Neuropathic Pain with Intravenous Magnesium” Masui. Japanese Journal of Anesthesiology, Sep. 1998, 47(9):1109-13. Abstract. |
Koinig, H., “Magnesium Sulfate Reduces Intra-and Postoperative Analgesic Requirements”, Anesthesia and Analgesia, Jul. 1998 87(1):206-10. |
Facchinetti, F., et al., “Oral Magnesium Successfully Relieves Premenstrual Mood Changes”, Obstetrics and Gynecology, Aug. 1991 78(2):177-81. |
De Souza, M.C., et al., “A Synergistic Effect of a Daily Supplement for 1 Month of 200mg Magnesium Plus 50mg Vitamin B6 for the Relief of Anxiety-Related Premenstrual Symptoms: A Randomized, Double-Blind, Crossover Study,” Journal of Women's Health & Gender-Based Medicine, Mar. 2000, 9(2):131-9. |
James, M.F., et al., “The Use of Magnesium Sulphate Infusions in the Management of Very Severe Tetanus”, Intensive Care Medicine, 1985, 11(1):5-12. |
Ringvist, I., et al., “Effects of Cold Pressor Test on Circulating Atrial Natriuretic Peptide 99-126 (ANP) in patients with Raynaud's Phenomenon and Influence of Treatment with Magnesium Sulphate and Nifedipine”, Clinical Physiology, May 1993, 13(3):271-80. |
Myrdal, U., et al., “Magnesium Sulphate Infusion Decreases Circulating Calcitonin Gene-Related Peptide (CGRP) in Women with Primary Raynaud's Phenomenon”, Clinical Physiology, Sep. 1994, 14(5):539-46. |
Pfaffenrath, V., et al., “Magnesium in the Prophylaxis of Migraine-A Double Blind Placebo Controlled Study”, Cephalagia, Oct. 1996, 16(6):436-40. |
Belch, J.L. “Temperature-Associated Vascular Disorders: Raynaud's Phenomenon and Erythromelalgia”, Chapter 22 in Lowe, GD, Tooke, JE, A Textbook of Vascular Medicine, London: Oxford University Press, 1996. |
Lepper, J., et al., “Effect of Magnesium Sulfate Infusion on Circulating Levels of Noradrenaline and Neuropeptide-Y-Like Immunoreactivity in Patients with Primary Raynaud's Phenomenon,” Angiology, Jul. 1994, 45(7):637-45. |
Ravn, H.B., “Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation”, Arteriosclerosis, Thrombosis, and Vascular Biology, Dec. 1997, 17(12):3620-5. |
Rauck, R.L., et al., “Refractory diopathic erythrommelalgia”, Anesthesia and Analgesia, 1996; 82(5):1097-101. |
Iseri, L.T. et al., “Magnesium: Nature's Physiologic Calcium Blocker”, American Heart Journal, 1984; 108(1):188-93. |